interferoninduc
transmembran
protein
play
role
rna
viral
restrict
human
cancer
progress
use
immunohistochem
stain
ffpe
tissu
identifi
subgroup
cervic
cancer
patient
protein
express
invers
relat
metastasi
guid
method
use
develop
isogen
doubl
null
cervic
cancer
model
order
defin
domin
pathway
trigger
presenc
absenc
signal
puls
silac
methodolog
identifi
hlab
domin
induc
protein
whose
synthesi
attenu
doublenul
cell
convers
swathip
mass
spectrometri
ectop
express
sbptag
identifi
hlab
domin
coassoci
protein
attenu
treat
doublenul
cell
proxim
ligat
assay
indic
hlab
interact
protein
parent
siha
cell
cell
surfac
express
hlab
attenu
treat
doublenul
cell
swathm
proteom
screen
cell
treat
sirna
cell
result
attenu
interferon
regul
protein
subpopul
includ
mhc
class
molecul
well
data
implic
function
mediat
stimul
protein
synthesi
includ
mhc
class
product
cancer
cell
data
togeth
suggest
prometastat
growth
associ
neg
cervic
cancer
relat
attenu
express
mhc
class
molecul
would
support
tumor
immun
escap
abbrevi
fasp
filteraid
sampl
prepar
fa
formic
acid
hla
human
leucocyt
antigen
ifn
interferon
interferoninduc
transmembran
receptor
interferonstimul
gene
interferon
regulatori
factor
mhc
major
histocompat
complex
ms
mass
spectrometri
nmwco
nomin
molecular
weight
cutoff
pb
phosphatebuff
salin
pla
proxim
ligat
assay
rt
room
temperatur
swathip
swath
immunoprecipit
sbp
twin
streptavidin
bind
protein
uplc
ultra
perform
liquid
chromatographi
correspond
author
interferon
ifn
pleiotrop
cytokin
produc
innat
immun
system
defens
respons
mani
biolog
function
describ
interferon
pathway
among
best
character
antitumor
activ
immunomodulatori
effect
antipathogen
antivir
activ
ifn
effect
reli
three
differ
type
receptor
type
type
ii
type
iii
ifn
increas
respons
broad
rang
factor
persist
viral
infect
dna
damag
agent
activ
jak
kinasestat
pathway
ultim
signal
cascad
regul
transcript
synthesi
interferon
stimul
gene
isg
type
ifn
facilit
antiprolif
proapoptot
pathway
wide
rang
cell
type
extens
use
antitumor
therapeut
agent
high
dose
ifn
use
cancer
therapi
activ
antitumor
immun
well
proapoptot
antiprolif
program
contrast
demonstr
sustain
low
level
ifn
caus
steadyst
express
interferon
resist
dna
damag
signatur
ird
compris
subset
interferonstimul
gene
ird
protein
promot
phenotyp
contribut
tumor
develop
resist
dna
damag
suppress
cell
toxic
metastasi
facilit
epithelialmesenchym
transit
prooncogen
receptor
compon
ird
pathway
basal
express
ifitm
protein
observ
cell
express
also
induc
type
type
ii
interferon
upregul
develop
radiat
resist
escap
proapoptot
antiprolif
effect
express
extens
report
mani
type
cancer
breast
cervix
colon
ovari
brain
oesophagu
cancer
high
express
correl
tumor
progress
lead
poor
outcom
previous
known
ifi
interferon
induc
protein
ifi
interferon
induc
protein
cluster
differenti
leucocyt
surfac
protein
membran
protein
play
key
role
restrict
antivir
immun
respons
belong
interferon
induc
transmembran
famili
ifitm
code
gene
locat
chromosom
flank
gene
ifitm
immunityrel
protein
famili
compos
short
aminotermin
carboxytermin
domain
two
transmembran
domain
cytoplasm
domain
slightli
differ
studi
demonstr
uniqu
express
cell
surfac
ifitm
famili
member
capabl
attenu
entranc
mani
human
anim
virus
suppress
entri
virus
influenza
viru
iav
west
nile
viru
dengu
viru
sar
coronaviru
filovirus
vsv
hcv
among
other
ifitm
famili
protein
inhibit
cytosol
entri
virus
prevent
fusion
viral
host
membran
proteinprotein
interact
network
ifitm
protein
inhibit
viral
propag
emerg
one
studi
use
yeast
twohybrid
methodolog
identifi
interact
vapa
turn
mediat
accumul
cholesterol
multivesicular
structur
reduc
fusion
intralumin
virioncontain
vesicl
endosom
membran
therebi
inhibit
viru
releas
cytosol
addit
differ
famili
member
exhibit
specif
viral
prefer
case
activ
control
filovirus
influenza
sar
report
focu
appli
methodolog
interactom
gene
edit
swathimmunoprecipit
mass
spectrometri
pulsesilac
mass
spectrometri
propos
respons
biochem
function
protein
chemic
reagent
obtain
sigma
unless
indic
otherwis
antibodi
thermofish
unless
indic
otherwis
siha
nullsiha
nullsiha
cell
line
grown
rpmi
medium
invitrogen
supplement
vv
fetal
bovin
serum
labtech
penicillinstreptomycin
invitrogen
incub
co
cervic
cancer
sampl
obtain
masaryk
memori
cancer
institut
patient
gave
written
consent
tissu
use
accord
local
ethic
regul
tissu
fix
formaldehyd
approxim
h
process
paraffin
wax
section
section
cut
antigen
retriev
sampl
probe
primari
antibodi
includ
protein
data
shown
protein
use
mabmhk
supplementari
fig
follow
stage
tissu
section
incub
secondari
antibodi
conjug
streptavidinhrp
section
incub
dab
dako
counterstain
haematoxylin
mount
visual
previous
describ
gener
null
doubl
null
cell
line
use
technolog
guid
rna
sequenc
design
tccaaggtcc
accgtgatca
gtcaacagtggccagccccc
guid
rna
clone
express
vector
transfect
cell
select
puromycin
sort
plate
use
fac
week
individu
clone
screen
absenc
andor
protein
express
western
blot
use
mabmhk
supplementari
fig
chromosom
dna
posit
clone
sequenc
final
valid
defin
precis
gene
edit
fig
chromosom
dna
extract
frozen
cell
pellet
follow
instruct
manual
gentra
puregen
cell
kit
qiagen
valid
edit
dna
sequenc
confirm
clone
genom
pcr
product
hold
vector
amplifi
entir
gene
bp
surround
guid
rna
target
site
follow
sanger
sequenc
sourc
bioscienc
servic
scotland
clone
transfect
affin
purif
protein
cdna
clone
pcr
express
vector
contain
sbp
tag
nterminu
code
region
sbp
vector
iba
siha
cell
grown
rpmi
duplic
transfect
cell
grown
approxim
confluenc
transfect
use
attracten
qiagen
cell
transfect
sbpempti
vector
control
cell
h
h
transfect
cell
treat
carrier
ngml
invitrogen
h
order
stabil
potenti
interferonactiv
interact
protein
cell
wash
twice
ice
cold
pb
scrape
buffer
contain
mm
kcl
mm
hepe
ph
mm
edta
mm
egta
mm
na
vo
mm
naf
vv
glycerol
proteas
inhibitor
mix
triton
incub
min
ice
centrifug
rpm
min
equal
amount
protein
use
perform
affin
captur
streptavidin
agaros
conjug
bead
millipor
prewash
pb
cell
lysat
ad
incub
h
rt
gentl
rotat
bind
protein
elut
buffer
contain
mm
hepe
ph
mm
dtt
urea
small
interf
rna
direct
human
qiagen
allstar
neg
control
flexitub
sirna
qiagen
use
transfect
siha
cell
h
cell
transfect
use
hiperfect
qiagen
follow
manufactur
instruct
perform
puls
silac
parent
siha
doubl
null
cell
singl
null
cell
grown
biolog
triplic
incub
silac
heavi
media
h
without
ngml
harvest
cell
isotop
pulselabel
use
silac
rpmiheavi
media
dunde
cell
product
uk
l
arginin
l
lysin
cell
harvest
buffer
contain
urea
tri
ph
total
protein
extract
measur
bradford
assay
protein
detect
use
follow
primari
antibodi
mous
monoclon
antibodi
gener
peptid
ident
mabmhk
moravian
biotechnolog
studi
first
descript
antibodi
name
mabmhk
therefor
detect
coexpress
protein
supplementari
fig
sourc
includ
rabbit
monoclon
cell
signal
mous
monoclon
bd
transduct
laboratori
rabbit
polyclon
antihlab
thermo
fisher
rabbit
polyclon
antibodi
cell
signal
mous
monoclon
antisbptag
sigma
mous
monoclon
sigma
mous
monoclon
antigapdh
abcam
protein
lyse
sampl
quantifi
use
protein
assay
dye
reagent
biorad
protein
resolv
sdspage
use
gel
transfer
onto
nitrocellulos
membran
amersham
protran
ge
healthcar
immunoblot
process
enhanc
chemiluminesc
ecl
parent
siha
doubl
null
cell
grown
mm
diamet
glass
coverslip
stimul
cell
treat
ngml
h
cell
fix
vv
paraformaldehyd
pb
min
room
temperatur
permeabil
use
triton
pb
min
cell
block
bsa
pb
min
primari
antibodi
incub
dilut
overnight
alexa
fluor
goat
antirabbit
igg
h
l
invitrogen
incub
secondari
antibodi
dilut
h
fluoresc
signal
detect
use
zeiss
axioplan
microscop
replic
describ
fig
legend
fluoresc
measur
use
imagej
softwar
cell
select
inform
extract
area
integr
densiti
mean
gray
valu
select
set
measur
analys
menu
region
fluoresc
select
background
imag
follow
formula
appli
cell
analyz
ctcf
integr
densiti
area
select
cell
mean
fluoresc
background
read
ctcf
correct
total
cell
fluoresc
parent
siha
doubl
null
cell
grown
process
describ
immunofluoresc
method
primari
antibodi
differ
speci
incub
fix
permeabil
cell
mhk
mous
mab
rabbit
polyclon
antihlab
dilut
overnight
assay
sigma
carri
follow
supplier
instruct
fluoresc
signal
detect
use
zeiss
axioplan
microscop
fluoresc
measur
use
imagej
softwar
review
standard
immunofluoresc
mass
spectrometr
experiment
screen
peptid
gener
use
fasp
cell
lysat
immunoprecipit
gradient
fraction
process
use
filteraid
sampl
prepar
protocol
fasp
urea
buffer
urea
tri
ph
ad
kda
spin
filter
column
microcon
protein
concentr
determin
use
rcdc
method
biorad
normal
sampl
ad
spin
filter
column
centrifug
g
min
urea
buffer
ad
mm
tri
phosphin
hydrochlorid
aldrich
mix
column
left
thermoblock
set
shake
rpm
centrifug
rpm
min
urea
buffer
mm
iodoacetamid
sigma
mix
use
thermomix
rpm
dark
min
maintain
static
min
room
temperatur
dark
sampl
centrifug
rpm
min
supernat
discard
solut
contain
mm
ammonium
bicarbon
ad
column
centrifug
rpm
min
step
repeat
one
time
column
place
new
collect
tube
low
bind
affin
mm
ammonium
bicarbon
ad
along
trypsin
dilut
trypsin
buffer
promega
ratio
column
incub
overnight
follow
day
column
centrifug
rpm
min
determin
peptid
concentr
perform
use
quantit
colorimetr
peptid
assay
pierc
thermoscientif
peptid
desalt
micro
spin
column
harvard
apparatu
usa
column
condit
three
time
acetonitril
acn
formic
acid
fa
centrifug
rpm
room
temperatur
min
column
wash
fa
centrifug
rpm
room
temperatur
min
column
hydrat
fa
min
follow
centrifug
rpm
room
temperatur
min
sampl
load
column
centrifug
rpm
min
wash
column
three
time
fa
peptid
elut
three
consecut
centrifug
rpm
min
use
acn
fa
subsequ
peptid
eluat
evapor
dissolv
acn
fa
three
distinct
mass
spectrometr
screen
use
manuscript
rational
replic
distinct
approach
follow
swathip
immunoprecipit
identifi
associ
protein
fig
immunoprecipit
immunoblot
vs
sbp
control
repres
experi
perform
least
three
time
repres
enrich
protein
fig
supplementari
tabl
process
label
free
swath
massspectrometri
technic
triplic
measur
foldchang
pvalu
quantifi
protein
list
supplementari
tabl
fig
ii
sirna
swathm
fig
b
target
sirna
deplet
siha
cell
perform
least
three
separ
experi
repres
deplet
protein
fig
perform
technic
triplic
use
two
differ
biolog
state
h
statist
rational
perform
two
biolog
state
equival
plate
cell
number
differ
time
interferon
exposur
rather
two
biolog
replic
time
point
due
variabl
induct
suppress
interferon
cascad
time
frame
thu
protein
observ
two
biolog
state
function
time
thought
higher
signific
analysi
perform
duplic
one
time
point
sampl
two
biolog
state
process
technic
triplic
labelfre
swath
analysi
fig
supplementari
tabl
iii
puls
silac
measur
protein
synthesi
function
genotyp
twelv
enzymat
digest
sampl
four
sampl
parent
siha
four
sampl
null
four
sampl
doubl
null
independ
biolog
triplic
process
use
isotop
label
amino
acid
separ
use
lcmsm
analysi
tabl
statist
rational
use
three
biolog
replic
one
inject
per
replic
rather
three
technic
replic
one
biolog
sampl
relat
dynam
variabl
interferon
dynam
use
biolog
triplic
common
overlap
deem
signific
possibl
variabl
cell
plate
interferon
cascad
peptid
load
precolumn
mm
id
mm
length
pepmap
particl
size
pore
size
separ
acclaim
pepmap
rslc
column
mm
id
length
mm
particl
size
mm
pore
size
nlmin
flow
rate
use
linear
gradient
b
min
b
min
b
min
aq
formic
acid
b
acn
aq
formic
acid
peptid
elut
column
introduc
orbitrap
elit
thermo
fisher
scientif
massachusett
usa
oper
data
depend
acquisit
mode
survey
scan
mz
perform
orbitrap
resolut
agc
target
ms
inject
time
follow
twenti
datadepend
scan
perform
ltq
linear
ion
trap
microscan
ms
inject
time
agc
data
mass
spectromet
process
either
use
proteom
discover
proteom
discover
employ
imbed
statist
tool
program
thermo
fisher
scientif
massachusett
usa
proteom
discover
process
data
use
mascot
engin
follow
search
set
databas
swissprot
human
april
enzym
trypsin
miss
cleavag
site
precursor
mass
toler
ppm
fragment
mass
toler
da
dynam
modif
carbamidomethyl
c
oxid
acetyl
protein
nterminu
result
search
submit
gener
final
report
consid
fdr
psm
peptid
group
level
uniqu
peptid
use
protein
quantif
silac
label
chosen
heavi
light
rel
quantif
valu
repres
heavylight
ratio
supplementari
tabl
process
consensu
workflow
subsequ
node
use
minora
featur
detector
precursor
ion
quantifi
featur
mapper
data
process
use
sequest
ht
engin
follow
search
set
databas
swissprot
sequenc
taxonomi
homo
sapien
updat
februari
enzym
trypsin
miss
cleavag
site
precursor
mass
toler
ppm
fragment
mass
toler
da
static
modif
carbamidomethyl
da
c
label
da
k
r
dynam
modif
oxid
peptid
terminu
da
metloss
acetyl
protein
terminu
da
result
search
submit
gener
final
report
fdr
use
percol
protein
quantif
statist
assess
biolog
triplic
uniqu
peptid
razor
peptid
use
rel
quantif
valu
repres
rel
peak
area
peptid
heavi
isotop
label
treat
untreat
cell
ratio
supplementari
tabl
label
free
quantit
perform
use
faspprocess
tryptic
digest
liquid
chromatographi
coupl
tandem
mass
spectrometri
eksig
ekspert
nanolc
sciex
california
usa
onlin
connect
tripletof
sciex
toronto
canada
mass
spectromet
cell
lysat
process
technic
triplic
prior
separ
peptid
concentr
desalt
cartridg
trap
column
id
mm
pack
sorbent
particl
size
thermo
fisher
scientif
waltham
usa
wash
use
trifluoroacet
acid
acetonitril
water
peptid
elut
use
gradient
acetonitrilewat
nlmin
use
capillari
emitt
column
nanospray
column
mm
new
object
massachusett
usa
selfpack
prontosil
aq
sorbent
particl
bischoff
leonberg
germani
mobil
phase
compos
vv
formic
acid
water
mobil
phase
b
compos
vv
formic
acid
acetonitril
gradient
elut
start
mobil
phase
b
first
min
proport
mobil
phase
b
increas
linearli
b
follow
min
output
separ
column
directli
coupl
ion
sourc
nanoelectrospray
nitrogen
use
dri
nebul
ga
temperatur
flow
dri
ga
set
psi
voltag
capillari
kv
pool
sampl
spectral
librari
measur
datadepend
posit
mode
ida
ms
precursor
mass
rang
set
mz
mz
mz
mz
ms
ms
cycl
time
cycl
intens
precursor
ion
fragment
subsequ
correspond
msm
spectra
measur
precursor
exclus
time
set
precursor
ion
intens
suspend
ida
experi
extract
mass
spectra
chromatogram
annot
deconvolut
perform
use
protein
pilot
sciex
toronto
canada
ms
msm
data
search
use
uniprotswissprot
databas
entri
restrict
homo
sapien
taxonomi
fix
modificationalkyl
cystein
use
iodoacetamid
digest
use
trypsin
set
search
fdr
analysi
perform
search
shotgun
data
decoy
search
databas
result
group
file
import
peakview
sciex
toronto
canada
protein
fdr
import
spectral
librari
protein
pull
swath
swath
mode
mass
spectromet
oper
high
sensit
posit
mode
precursor
rang
set
mz
mz
divid
precursor
ion
window
width
da
da
overlap
accumul
time
ms
per
swath
window
duti
cycl
enabl
acquisit
least
data
point
across
chromatograph
peak
product
ion
scan
mz
mz
data
extract
perform
peakview
sciex
toronto
canada
spectral
librari
retent
time
window
extract
manual
set
min
pull
swath
sirna
swath
fig
protein
quantif
perform
use
peptid
transit
per
protein
defin
statist
signific
protein
scope
peptid
use
quantif
narrow
peptid
confid
higher
without
variabl
modif
protein
sum
peak
area
normal
use
total
area
sum
option
markerview
sciex
toronto
canada
sampl
compar
pairwis
use
pair
ttest
mass
spectrometr
data
deposit
proteomexchang
consortium
via
pride
partner
repositori
dataset
identifi
review
detail
includ
usernam
ebiacuk
password
parent
siha
doubl
null
cell
grown
rpmi
supplement
fb
penstrep
pyruv
confluenc
plate
treat
ngml
h
cell
harvest
use
accutas
sigmaaldrich
centrifug
rpm
min
rpmi
kept
ice
bsa
pb
min
primari
antibodi
hlab
dilut
bsapb
cell
centrifug
cell
pellet
resuspend
dilut
primari
antibodi
amount
bsapb
control
sampl
incub
min
room
temperatur
tube
rotat
tripl
wash
icecold
bsapb
cell
incub
secondari
antibodi
abcam
goat
antirabbit
igg
h
l
dylight
dilut
tube
rotat
min
room
temperatur
tripl
wash
icecold
bsapb
cell
resuspend
bsapb
kept
ice
measur
sampl
measur
facsvers
bd
bioscienc
data
analyz
use
facsuit
softwar
bd
bioscienc
neg
control
without
primari
antibodi
prepar
sampl
hla
express
cell
surfac
count
fitc
median
fluoresc
intens
mfi
divid
mfi
neg
control
two
independ
experi
perform
two
independ
isol
doubl
null
cell
two
differ
hla
antibodi
hlaa
data
shown
hlab
fig
identifi
clinic
relev
model
dissect
signal
function
oncogen
factor
sever
cancer
cell
attenu
protein
express
inhibit
growth
invas
andor
migrat
cancer
cell
patient
subgroup
clinic
relev
express
data
welldefin
develop
panel
monoclon
antibodi
ntermin
peptid
high
homolog
supplementari
fig
b
would
allow
develop
monoclon
antibodi
detect
coexpress
protein
aim
use
tool
screen
larg
panel
human
cancer
express
protein
would
identifi
clinic
relev
model
focu
dissect
signal
pathway
monoclon
antibodi
chosen
name
mabmhk
supplementari
fig
bind
antigen
rang
human
cancer
cell
supplementari
fig
cancer
cell
exhibit
express
lymphoma
cell
line
whunhl
supplementari
fig
studi
confirm
mabmhk
bind
protein
defin
use
singl
singl
null
doubl
null
cell
see
mabmhk
use
screen
larg
panel
archiv
formalinfix
human
cancer
tissu
identifi
potenti
clinic
relev
model
could
detect
differenti
express
breast
cancer
colon
cancer
oesophagu
cancer
data
shown
could
also
detect
differenti
express
protein
cervic
cancer
array
fig
squamou
cervic
cancer
sampl
express
either
high
level
fig
lower
level
fig
undetect
level
antigen
fig
cervic
adenocarcinoma
often
exhibit
high
express
fig
interestingli
normal
squamou
cervic
epithelium
exhibit
high
express
basal
stem
cell
pluripot
layer
fig
differenti
cell
layer
conclud
cervic
cancer
specimen
posit
protein
use
mabmhk
fig
top
panel
also
interest
statist
signific
invers
associ
protein
express
number
lymph
node
metastas
patient
fig
bottom
panel
ration
discuss
base
data
emerg
develop
doubl
null
cell
line
use
crisprguid
rna
methodolog
implic
mediat
growth
control
cancer
cell
activ
pathway
also
implic
growth
stimulatori
role
cervic
squamou
cancer
posit
cervic
cancer
cell
line
siha
exhibit
induc
protein
fig
focus
use
cervic
cancer
cell
line
siha
model
identifi
depend
signal
pathway
order
continu
develop
cervic
cancer
cell
model
reflect
clinic
data
posit
neg
cancer
fig
set
develop
doubl
null
cell
line
model
first
gener
isogen
null
cell
panel
gene
edit
valid
guid
rna
knockout
mice
viabl
like
would
abl
gener
null
cell
guid
rna
target
exon
gene
figur
clone
cell
transfect
select
resist
puromycin
allow
stabl
integr
target
guid
rna
cassett
cell
clone
chosen
sequenc
across
guid
rna
target
site
fig
use
pcr
fig
allel
gene
edit
repres
clone
creat
two
distinct
frameshift
fig
examin
four
repres
null
cell
dna
damag
respons
assay
line
shown
either
chemosensit
xirradi
sensit
data
shown
sinc
singl
knockout
clone
behav
similarli
chose
one
repres
null
cell
line
continu
studi
gene
next
target
use
guid
rna
methodolog
fig
creat
doubl
null
cell
fig
null
mice
mice
entir
ifitm
chromosom
locu
delet
also
viabl
creat
isogen
cell
model
remov
redund
interact
landscap
especi
report
interact
vapa
immunoblot
confirm
protein
detect
doubl
null
cell
respect
fig
lane
chose
repres
doublenul
cell
line
subsequ
studi
given
one
establish
effector
evalu
respons
protein
synthesi
stimul
parent
siha
singl
null
doubl
null
cell
parent
siha
singl
null
doubl
null
cell
treat
heavi
isotop
amino
acid
label
media
silac
method
h
absenc
presenc
fig
cell
lysat
process
fasp
analyz
protein
synthesi
use
mass
spectrometri
silac
methodolog
subject
analysi
random
error
associ
multipl
step
approach
includ
cell
plate
biolog
replic
switch
heavi
isotop
media
cell
recoveri
plastic
plate
cell
lysi
centrifug
filter
assist
trypsin
tryptic
peptid
recoveri
process
error
reduc
employ
multipl
replic
n
highlight
previous
highlight
import
biolog
replic
inher
error
multipl
step
process
plot
data
averag
three
replic
individu
point
three
replic
supplementari
fig
fig
domin
respons
protein
identifi
post
label
protein
supplementari
fig
vs
attenu
isotop
label
peptid
recov
biolog
triplic
doubl
null
cell
supplementari
fig
suggest
partial
depend
upon
signal
confirm
use
transcript
report
assay
data
shown
data
provid
degre
confid
methodolog
abl
identifi
known
respons
target
protein
whose
synthesi
detect
hour
postisotop
label
includ
supplementari
fig
known
link
interferon
signal
known
regul
accuraci
aug
codon
select
scan
preiniti
complex
might
prove
involv
regul
interferon
depend
antivir
mrna
select
nevertheless
three
protein
also
supplementari
fig
also
known
respons
protein
valid
methodolog
use
measur
quantit
chang
protein
synthesi
three
protein
exhibit
equival
protein
synthesi
rate
parent
doublenul
cell
model
indic
doubl
null
retain
mani
key
regulatori
featur
parent
cell
suggest
mani
ifn
regulatori
featur
doubl
null
cell
retain
despit
select
process
creat
cell
model
post
treatment
siha
cell
hla
famili
member
protein
detect
fig
vs
indic
methodolog
detect
known
induc
protein
post
treatment
isotop
label
fig
immunohistochem
analysi
protein
express
cervic
cancer
use
mabmhk
formalinfix
paraffinembed
cervic
carcinoma
tissu
process
state
experiment
procedur
use
mabmhk
bind
share
epitop
ntermin
domain
supplementari
fig
b
peptid
attenu
fig
consist
earli
transient
induct
synthesi
mhc
class
molecul
fig
vs
quantifi
biolog
triplic
fig
three
major
hla
allel
exhibit
attenu
synthesi
doubl
null
cell
defin
use
tryptic
peptid
coverag
supplementari
fig
isotop
label
tryptic
peptid
also
observ
earli
interferon
respons
supplementari
fig
isotop
label
peptid
recoveri
h
attenu
doubl
null
cell
quantifi
biolog
triplic
fig
suggest
protein
synthesi
larg
depend
contrast
protein
synthesi
h
appear
larg
quantifi
biolog
triplic
fig
provid
anoth
intern
control
anoth
wellknown
induc
protein
exhibit
equival
synthesi
doubl
null
cell
quantifi
biolog
triplic
fig
indic
one
key
regulatori
featur
doubl
null
cell
product
remain
intact
data
first
demonstr
use
pulsesilac
methodolog
siha
cell
model
reflect
classic
respons
induct
mhc
class
molecul
fig
vs
supplementari
fig
also
note
attenu
hlaa
hlab
hlac
protein
synthesi
h
treatment
doubl
null
cell
compar
parent
siha
fig
vs
order
determin
delet
alon
impact
set
gene
product
parent
siha
cell
parallel
treat
silac
heavylabel
media
h
doubl
doubl
null
cell
depend
induct
protein
synthesi
attenu
hour
post
label
null
cell
supplementari
fig
vs
suggest
depend
upon
elev
protein
synthesi
base
equival
induct
null
cell
fig
hlab
protein
synthesi
attenu
hour
treatment
singl
null
cell
fig
synthesi
also
attenu
singl
null
cell
fig
togeth
data
suggest
mhc
class
famili
member
requir
least
maxim
stimul
protein
synthesi
softwar
use
identifi
hla
orthologu
pulsesilac
screen
fig
discrimin
hlaa
hlab
hlac
base
tryptic
peptid
sequenc
supplementari
fig
focu
hlab
show
accur
identif
hlab
specif
peptid
also
member
ird
pathway
thu
valid
hlab
protein
express
orthogon
assay
determin
whether
appar
reduct
hlab
protein
synthesi
reduct
doubl
null
cell
reflect
total
steadi
state
protein
level
subcellular
local
plasma
membran
first
immunofluoresc
hlab
defin
parent
siha
doubl
null
cell
parent
siha
cell
reveal
signific
induct
hlab
immunoreact
h
treatment
fig
vs
quantifi
contrast
basal
hlab
protein
express
attenu
doubl
null
cell
treatment
fig
vs
quantit
total
immunofluoresc
absenc
presenc
parent
siha
doubl
null
cell
also
confirm
attenu
hlab
induct
null
cell
panel
fig
vs
consist
reduc
protein
synthesi
observ
hlab
puls
silac
quantit
doubl
null
cell
domin
subcellular
local
hlab
thought
resid
cell
surfac
antigen
present
carrier
therefor
evalu
whether
hlab
express
plasma
membran
alter
doubl
null
cell
use
fac
analysi
nonpermeabil
cell
two
independ
doubl
null
cell
clone
use
form
biolog
replic
comparison
parent
siha
cell
line
twentyfour
hour
post
treatment
hlab
elev
plasma
membran
parent
siha
cell
line
data
shown
quantit
reveal
reduc
level
hlab
independ
doubl
null
biolog
replic
absenc
presenc
fig
data
indic
fig
methodolog
approach
identifi
signal
pathway
alter
doubl
null
cell
indic
cell
parent
siha
singl
null
doubl
null
pretreat
carrier
h
media
replac
isotop
label
media
carrier
h
cell
harvest
lyse
tryptic
peptid
process
analysi
mass
spectrometri
ms
indic
experiment
procedur
caption
next
page
reduc
synthesi
hlab
doubl
null
cell
fig
impact
subcellular
local
plasma
membran
next
also
examin
whether
direct
proteinprotein
interact
hlab
sinc
cosynthes
transmembran
local
cell
surfac
ird
compon
vivo
proxim
ligat
assay
emerg
methodolog
shown
demonstr
associ
two
endogen
express
protein
fix
cell
without
need
harsh
lysi
method
consid
situ
mimic
immunoprecipit
assay
proxim
ligat
assay
identifi
proteinprotein
interactionassoci
distanc
nm
upper
rang
observ
use
fret
nm
methodolog
detect
authent
endogen
protein
situ
reli
transfect
artifici
gfptag
protein
vector
evalu
whether
hlab
coassoci
use
methodolog
use
antibodi
hlab
mabmhk
bind
protein
supplementari
fig
signific
proteinprotein
interact
observ
treat
cell
repres
imag
fig
foci
absent
doubl
null
cell
fig
togeth
data
valid
pulsesilac
data
identifi
hlab
downstream
effector
easili
visual
use
immunofluoresc
situ
tabl
cell
incub
h
b
f
data
plot
function
fold
chang
heavylight
peptid
intens
triplic
repres
x
zaxi
sampl
gl
repres
peptid
use
quantif
biolog
triplic
highlight
demonstr
protein
induc
independ
j
protein
depend
g
hlab
l
data
shown
could
identifi
proteinprotein
associ
protein
use
proxim
ligat
data
shown
thu
use
independ
assay
orthogon
valid
induct
develop
sbptag
express
construct
order
ectop
express
protein
parent
siha
cell
design
methodolog
captur
associ
protein
transfect
express
could
detect
migrat
higher
mass
due
sbp
tag
endogen
protein
parent
siha
cell
fig
lane
vs
lane
specif
captur
affin
purif
follow
express
doubl
null
cell
fig
tabl
data
first
highlight
detect
peptid
belong
homolog
sequenc
protein
fig
fig
sinc
bait
protein
presum
detect
isoform
serv
intern
posit
control
fig
nevertheless
may
also
interact
previous
identifi
interact
protein
vapa
also
detect
fig
c
supplementari
tabl
protein
signific
pvalu
enrich
treat
cell
rel
nontreat
cell
fig
c
supplementari
tabl
includ
sever
protein
involv
cellcel
cell
matrix
interact
includ
cornifin
desmocolin
jup
hornerin
desmoglein
fig
supplementari
tabl
suggest
pathway
interact
membranedepend
cellcel
commun
enrich
higher
confid
target
treat
cell
also
suggest
treatment
may
requir
fulli
activ
protein
interact
landscap
interestingli
protein
relat
signal
also
detect
hlab
fig
c
immunoblot
also
confirm
quantit
three
independ
assay
perform
assay
two
independ
biolog
replic
assay
fluoresc
measur
least
cell
per
condit
fluoresc
measur
use
imagej
softwar
statist
studi
perform
anova
bonferroni
correct
pvalu
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
attenu
doubl
null
cell
stimul
fig
contrast
free
protein
remain
equival
cell
fig
suggest
synthesi
detect
use
puls
silac
directli
link
ifn
stimul
protein
conjug
ratio
chang
conjug
free
summar
fig
togeth
orthogon
valid
hlab
consist
puls
silac
data
protein
requir
maxim
induct
hlab
treat
cell
unabl
complement
gene
back
doublenul
siha
cell
stimul
hlab
protein
level
treat
cell
data
shown
took
independ
approach
defin
domin
signal
pathway
whether
overlap
signal
protein
identifi
use
pulsesilac
experiment
method
although
major
analys
identifi
hlab
protein
express
chang
use
doubl
null
cell
creat
singl
null
cell
reveal
similar
reduct
hlab
treatment
fig
g
l
examin
depend
steadyst
proteom
level
use
target
sirna
treatment
parent
siha
cell
fig
lane
vs
determin
attenu
method
gave
rise
similar
proteom
chang
howev
caveat
method
similar
plasmid
transfect
doubl
strand
rna
also
induc
depend
transcript
interferon
respons
accordingli
also
found
sirna
transfect
methodolog
induc
transcript
respons
data
shown
nevertheless
sirna
power
tool
determin
gene
depend
cell
model
parent
siha
cell
treat
h
control
sirna
sirna
tabl
select
bind
protein
detect
mass
spectrometri
enrich
without
stimul
supplementari
tabl
cell
parent
siha
lane
doubl
null
lane
transfect
empti
vector
treat
sampl
process
immunoblot
antibodi
free
monomer
protein
highlight
well
conjug
free
protein
express
similar
level
cell
whilst
conjug
attenu
doubl
null
cell
lane
vs
suggest
protein
synthesi
link
coval
conjug
condit
condit
attenu
protein
synthesi
observ
use
puls
silac
fig
antibodi
protein
use
load
control
indic
e
free
conjug
quantifi
use
imagej
softwar
rel
unit
au
defin
express
function
free
conjug
parent
doubl
null
cell
rel
chang
conjug
free
au
parent
cell
rel
chang
conjug
free
au
doubl
null
cell
strike
select
reduct
interferonrespons
protein
use
label
free
quantit
mass
spectrometri
time
point
fig
supplementari
tabl
protein
includ
also
compon
interferonstimul
dna
damag
resist
signatur
protein
interestingli
hlab
also
lower
treatment
siha
cell
target
sirna
howev
one
notabl
differ
pulsesilac
fig
vs
sirna
methodolog
fig
defin
use
puls
silac
fig
whilst
use
sirna
methodolog
fig
impact
target
sirna
steadyst
proteom
immunoblot
demonstr
sirna
attenu
protein
level
cell
treat
indic
control
target
sirna
two
time
point
captur
overlap
transient
dynam
interferon
signal
cascad
lysat
immunoblot
mabmhk
antibodi
mhk
monoclon
antibodi
cross
react
common
ntermin
epitop
see
supplementari
fig
quantifi
protein
load
control
gapdh
highlight
b
evalu
total
steadyst
proteom
respons
sirna
target
siha
cell
use
swathm
data
supplementari
tabl
impact
sirna
treatment
h
time
point
point
focu
sinc
sirna
treatment
activ
transcript
respons
twotim
frame
data
shown
screen
conduct
experiment
condit
consid
respons
activ
rna
treatment
data
two
biolog
state
plot
fold
chang
protein
level
use
swathm
function
either
time
point
key
protein
whose
steadyst
level
suppress
sirna
treatment
highlight
red
lower
left
quadrant
c
signal
model
puls
label
use
silac
methodolog
identifi
domin
protein
synthes
treatment
form
intern
posit
control
consist
classic
jakstat
respons
treatment
produc
mrna
translat
respons
treatment
includ
interferon
effector
ii
contrast
stimul
factor
depend
includ
mhc
class
molecul
fig
l
sirnamedi
deplet
repres
orthogon
assay
identifi
reduct
mhc
class
molecul
fig
protein
reflect
distinct
mechan
control
although
puls
silac
reveal
synthesi
fig
steadi
state
level
protein
reduc
target
deplet
siha
cell
fig
data
suggest
turnov
protein
might
depend
synthesi
independ
howev
methodolog
complic
compar
directli
sinc
sirna
methodolog
use
intrins
rna
signal
doubl
strand
rna
stimul
without
exogen
ad
whilst
puls
silac
use
without
rna
ligand
altogeth
data
place
protein
coordin
synthesi
andor
steadi
state
level
subset
key
player
respons
notabl
induct
mhc
class
molecul
depend
manner
identifi
coordin
signal
pathway
potenti
clinic
relev
fig
recent
observ
lower
hlaa
hlab
hlac
allel
correl
poor
prognosi
enhanc
metastat
growth
cervic
cancer
consist
exist
hla
signal
pathway
regul
cervic
cancer
outcom
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
fig
supplementari
tabl
might
reflect
fact
rna
ligand
sirna
induc
addit
rnaactiv
pathway
target
sirna
proteom
screen
alon
conclus
puls
silac
methodolog
singl
null
fig
sirna
treatment
use
target
sirna
parent
siha
cell
fig
gave
rise
overlap
proteom
chang
mainli
hlab
data
suggest
might
alon
function
effector
two
protein
howev
rule
role
singl
null
cell
sinc
also
reduc
target
sirna
treatment
siha
cell
fig
thu
might
cooper
mediat
effect
ifitm
protein
famili
identifi
whole
genom
sirna
screen
rna
viru
restrict
factor
molecular
function
ifitm
famili
antivir
respons
begin
defin
yeasttwo
hybrid
bait
use
methodolog
discov
new
proteinprotein
interact
within
ifitm
famili
mediat
viral
restrict
proteinprotein
interact
identifi
vesiclemembraneproteinassoci
protein
vapa
vapa
interact
occur
three
distinguish
assay
nevertheless
studi
focus
defin
vapa
interact
result
reduct
vapa
bind
oxysterolbind
protein
osbp
disrupt
cholesterol
homeostasi
prevent
viral
matur
also
report
bind
vapa
yet
clear
whether
play
minor
redund
role
control
cholesterolmedi
viral
matur
interestingli
vapa
also
identifi
swathip
use
sbptag
fig
consist
vapa
domin
interactor
ifitm
famili
addit
vapa
palmitoyl
famili
member
report
requir
antivir
function
whether
antivir
associ
vapa
palmitoyl
ifitm
famili
impact
cancer
growth
control
yet
known
ifitm
famili
also
report
role
oncogen
andor
prometastat
cancer
cell
growth
known
antivir
prooncogen
function
ifitm
famili
overlap
within
famili
well
document
prometastat
role
ifitm
famili
member
partial
resid
plasma
membran
also
ifitm
famili
member
compon
interferonregul
dna
damag
resist
ird
pathway
ird
contain
subset
approxim
interferon
respons
gene
upregul
late
viral
respons
upregul
develop
radiat
resist
upregul
result
chronic
exposur
lower
level
type
type
ii
interferon
ird
pathway
express
mediat
unphosphoryl
stimul
interestingli
two
ird
gene
hlab
induc
exposur
manner
fig
unpublish
data
also
indic
singl
null
cell
xray
sensit
cisplatinsensit
consist
hypothesi
express
link
chemo
irradi
resist
mechan
wherebi
regul
chemoresist
prometastat
cell
signal
event
mechanist
defin
report
begin
set
biochem
assay
could
shed
light
domin
cancerassoci
function
first
aim
identifi
clinic
relev
human
cancer
model
studi
ifitm
famili
protein
requir
us
develop
panspecif
antibodi
bind
protein
supplementari
fig
result
focu
cervic
cancer
fig
exhibit
high
medium
express
protein
fig
particular
interest
invers
correl
protein
express
lymph
node
metastasi
fig
suggest
loss
protein
express
correl
evas
immun
system
prooncogen
would
cervic
cancer
panel
reveal
invers
correl
express
cancerposit
lymph
node
patient
becom
appar
two
distinct
mode
metastat
cell
growth
first
classic
defin
metastasi
due
enhanc
invas
migrat
secondari
tissu
nich
second
repres
metastasi
due
cancer
cell
escap
immun
surveil
cancer
might
inde
proinvas
depend
microenviron
tissu
type
lead
poor
clinic
prognosi
methodolog
highlight
classic
prometastat
role
includ
overexpress
ectop
transfect
plasmid
encod
gene
attenu
gene
express
use
target
sirna
experiment
approach
inde
promot
cancer
cell
growth
andor
cell
invas
ie
model
metastat
growth
consist
use
clinic
materi
protein
often
shown
literatur
overproduc
cancer
use
immunohistochemistri
often
correl
poor
prognosi
howev
data
review
use
cervic
cancer
fig
indic
two
distinct
state
cervic
cancer
respect
express
neg
cervic
cancer
might
also
proinvas
due
immun
escap
base
data
indic
domin
protein
whose
synthesi
depend
use
puls
silac
methodolog
fact
hla
famili
member
fig
hla
famili
member
compon
ird
play
role
antivir
immun
present
viral
peptid
mhc
class
system
hla
express
link
immun
reject
cancer
cell
suggest
although
might
prooncogen
condit
signal
would
presum
function
tumor
suppressor
signal
via
engag
tcell
hla
posit
cancer
might
metastas
produc
neoantigen
present
mhc
class
molecul
keep
primari
tumor
local
chronic
state
equilibrium
immun
system
cancer
contrast
might
expect
produc
lower
amount
mhc
class
molecul
follow
stimul
fig
result
lower
neoantigen
express
immun
escap
metastasi
hypothes
consist
two
clinic
observ
cervic
cancer
first
invers
correl
exist
express
lymphnod
posit
cancer
fig
second
recent
studi
highlight
lower
mhc
class
express
also
predict
poor
prognosi
cervic
cancer
data
also
consist
sever
studi
highlight
elev
rate
metastat
cancer
cell
growth
vivo
invers
correl
mhc
class
express
includ
delet
mhc
class
locu
although
express
detect
cancer
cell
fig
interest
protein
express
observ
confin
basal
stem
cell
layer
repres
normal
tissu
control
use
immunohistochemistri
fig
e
express
observ
even
one
cell
layer
basal
layer
squamou
human
skin
basal
layer
reflect
squamou
stem
cell
transcript
factor
phosphoryl
posit
stem
cell
popul
uv
irradi
thu
express
might
reflect
role
squamou
stem
cell
pluripot
mani
sampl
reflect
normal
human
cervic
epithelium
case
exhibit
strong
stain
basal
layer
data
shown
cours
studi
human
protein
atla
also
popul
immunohistochem
librari
express
pattern
protein
normal
tissu
see
librari
protein
also
confin
basal
stem
cell
layer
normal
squamou
oesophagu
cervix
oral
mucosa
supplementari
fig
togeth
data
would
suggest
might
play
role
squamou
stem
cell
physiolog
express
appear
specif
confin
basal
layer
express
suprabas
normal
squamou
cell
normal
squamou
cervic
epithelium
use
patient
undergo
screen
cervic
cancer
dysplasia
rule
role
hpv
express
normal
cervic
cell
howev
oesophagu
squamou
epithelium
also
exhibit
protein
express
basal
cell
normal
squamou
epithelium
protein
atla
supplementari
fig
normal
oesophagu
note
hpv
infect
would
suggest
express
protein
basal
cell
relat
hpv
statu
signal
pathway
might
trigger
basal
protein
express
squamou
stem
cell
popul
precis
defin
howev
mrna
level
differenti
express
pattern
gene
express
identifi
uteri
mice
correl
pattern
gene
express
express
data
might
suggest
role
wnt
signal
upstream
regul
stem
cell
focu
cervic
cancer
model
understand
cancerassoci
role
interest
consid
rna
viral
restrict
factor
hpv
infect
risk
factor
cervic
cancer
progress
evid
might
posit
cofactor
dna
viru
viral
propag
data
defin
hpv
statu
cervic
cancer
analyz
fig
main
clinic
approv
assay
diagnost
posit
cancer
cell
close
relat
persist
viral
infect
develop
cancer
failur
immun
respons
exampl
cervic
well
vulvar
intraepitheli
neoplasia
precancer
condit
character
sustain
infect
clinic
studi
show
favor
prognosi
relat
increas
cytotox
follow
robust
cell
respons
induc
vaccin
vaccin
deliv
high
dose
specif
antigen
oncoprotein
mediat
mhcbind
peptid
complex
present
similar
outcom
also
observ
vaccin
preclin
mous
model
hpv
posit
cervic
cancer
signific
correl
mhc
class
found
mhc
class
ii
express
malign
cell
tcell
infiltr
til
human
ovarian
cancer
posit
prognost
factor
thu
might
dual
role
stimul
hpv
propag
also
suppress
cancer
escap
immun
surveil
one
key
approach
use
evalu
role
depend
protein
product
util
guid
rna
creat
isogen
knockout
cell
outset
reli
less
use
sirna
deplet
sinc
would
give
transient
reduct
target
protein
also
sirna
induc
interferon
respons
data
shown
would
complic
analysi
interferonrespons
natur
protein
interact
visual
measur
nevertheless
sirna
use
final
orthogon
approach
defin
signal
event
fig
b
contrast
limit
use
gene
knockout
tool
reduc
express
protein
requir
loss
protein
lethal
event
case
knockout
mice
report
viabl
thu
unexpect
abl
gener
singl
null
doubl
doubl
null
cell
panel
fig
howev
unabl
gener
singl
null
cell
experi
carri
parallel
report
manuscript
data
shown
use
isogen
cell
panel
abl
determin
whether
defect
depend
protein
synthesi
use
puls
silac
methodolog
chose
use
pulsesilac
approach
identifi
isotop
label
tryptic
peptid
signific
fold
chang
treatment
alter
doubl
singl
null
cell
significantli
suppress
protein
doubl
singl
null
cell
treatment
mhc
class
orthologu
encod
hlaa
hlab
hlac
gene
fig
ration
data
suggest
invers
correl
protein
hla
express
metastat
growth
cervic
cancer
interferonrespons
protein
also
attenu
doubl
null
cell
singl
singl
null
cell
treatment
fig
fact
hlab
enrich
protein
affin
purif
treatment
fig
suggest
cooper
activ
exist
two
protein
inde
hlab
interact
situ
treatment
fig
highconfid
protein
use
swathip
mass
spectrometri
fig
data
suggest
two
protein
directli
involv
depend
respons
also
compon
interferon
immun
respons
gene
cluster
suppress
stem
cell
pluripot
gene
product
express
suggest
like
hla
suppress
suppress
might
coincid
immun
escap
case
signal
see
defect
free
monomer
doubl
null
cell
reduct
conjug
higher
molecular
mass
adduct
fig
data
suggest
conjug
protein
interferon
stimul
might
play
coordin
role
depend
immunetumor
cell
interact
overproduct
report
previous
stabil
consist
data
detect
complex
fig
ubiquitin
might
counteract
stimulatori
effect
antivir
function
protein
ubiquitin
regul
andor
coordin
fashion
defin
data
togeth
provid
novel
biochem
pathway
relev
cancer
associ
function
correl
interferonrespons
natur
signal
mediat
depend
protein
product
mhc
class
protein
fig
whilst
mainten
protein
respons
involv
differ
signal
mechan
fig
antigen
present
signal
event
import
antivir
signal
well
immun
regul
cancer
cell
immunecanc
synaps
research
shed
light
reduct
hla
impact
oncogen
signal
andor
antivir
activ
respons
express
supplementari
data
articl
found
onlin
http
